Selection and enrichment of aptamers
Info Center
Home » Aptamer » Aptamer Screening » Selection and enrichment of aptamers

Selection and enrichment of aptamers

Date:2026-01-04

What are Aptamers?

Aptamers are single-stranded DNA or RNA oligonucleotides that fold into specific 3D shapes, enabling them to bind with high affinity and specificity to a target molecule (e.g., proteins, small molecules, cells, viruses). They are often termed “chemical antibodies.”

The process to discover them is called SELEX (Systematic Evolution of Ligands by Exponential Enrichment).


The Core Principle: SELEX

SELEX is an iterative, in vitro evolutionary process that mimics natural selection. It starts with a vast random library (10¹³–10¹⁵ unique sequences) and enriches those that bind to the target over multiple rounds.

Key Steps in a Single SELEX Cycle:

  1. Library Preparation:

    • A synthetic oligonucleotide library is created with a central random region (20–60 nucleotides) flanked by fixed primer-binding sites for PCR amplification.

  2. Incubation (Binding):

    • The library is incubated with the target under controlled conditions (buffer, temperature, time). A portion of the diverse sequences will bind to the target with varying affinity.

  3. Separation (Partitioning):

    • This is the most critical step. Bound sequences (the “hits”) must be efficiently separated from unbound ones. Methods include:

      • Immobilized Targets: Target is fixed on a column, beads, or filter. Unbound sequences are washed away.

      • Nitrocellulose Filter Binding: For protein targets; protein-nucleic acid complexes are retained.

      • Magnetic Bead Separation: Very common and versatile.

      • Capture-SELEX: For small molecules, using an immobilized capture oligo.

      • Cell-SELEX: Using whole, live cells as complex targets.

  4. Elution (Recovery):

    • Bound aptamers are released from the target, often by denaturation (heat, chaotropic agents) or specific competitive elution.

  5. Amplification:

    • The recovered pool is amplified using PCR (for DNA-SELEX) or RT-PCR (for RNA-SELEX) to generate a new, enriched library for the next round.

    • Counter-Selection (Negative Selection): Often used to improve specificity. The pool is incubated with non-target matrices (e.g., blank beads, related proteins) to remove non-specific binders before the positive selection step.

  6. Purification:

    • The PCR product is purified (e.g., gel extraction, strand separation for ssDNA generation) to prepare for the next round.

This cycle is repeated (typically 8-15 rounds), with increasing stringency (e.g., reduced incubation time, more stringent washes) to favor the highest-affinity binders.


Enrichment and Evolution

  • Early Rounds: Goal is to enrich the pool. Many different, moderate-affinity sequences are carried forward.

  • Later Rounds: Increasing stringency drives evolution. Competition favors sequences with the strongest binding kinetics (high Kd, low Koff rates). The pool’s diversity collapses, converging on a few dominant sequence families.


Post-SELEX: Identification and Characterization

  1. Cloning & Sequencing: The final enriched pool is cloned into bacteria or sequenced directly via High-Throughput Sequencing (HTS).

  2. Bioinformatics: HTS data is analyzed to identify enriched sequence clusters and consensus motifs.

  3. Synthesis & Testing: Individual candidate aptamers are chemically synthesized and their affinity (e.g., by Surface Plasmon Resonance), specificity, and function are validated.


Key Modern SELEX Variations

To address challenges like long duration, low success rates, or specific applications:

  • Capillary Electrophoresis (CE)-SELEX: High-efficiency separation based on mobility shift.

  • Toggle-SELEX: Alternates selection between two related targets (e.g., human and mouse protein) to generate cross-reactive aptamers.

  • Cell-SELEX: Generates aptamers against complex cell-surface biomarkers (e.g., for cancer).

  • In Vivo SELEX: Selection occurs within a living organism to find functional aptamers in a physiologically relevant environment.

  • High-Throughput (HT)-SELEX: Combines automation and HTS from early rounds for faster, more data-rich selections.


Challenges & Considerations

  1. Target Purity/Conformation: Especially for proteins, native conformation is critical.

  2. Amplification Bias: PCR can favor certain sequences for reasons unrelated to binding.

  3. Polymerase Errors: Can introduce beneficial mutations but also noise.

  4. “Matrix” vs. “Epitope” Binding: Ensure selection is against the desired target, not the immobilization surface (e.g., streptavidin bead).

  5. Time and Cost: Traditional SELEX can be labor-intensive, though automation is changing this.

Applications of Selected Aptamers

  • Diagnostics: Biosensors (aptasensors), point-of-care tests.

  • Therapeutics: As antagonist drugs or targeted delivery vehicles (“aptamer-drug conjugates”).

  • Research Tools: Protein detection, inhibition, and cellular targeting.

  • Analytical Chemistry: Stationary phases in affinity chromatography.

Summary

The selection and enrichment of aptamers via SELEX is a powerful in vitro evolution technique that transforms a vast random nucleic acid library into a small set of high-affinity, specific binders. Continuous innovations in partitioning methodsautomation, and sequencing have dramatically increased the efficiency and success rate of aptamer discovery, expanding their potential in medicine and biotechnology.